The FDA has approved fewer generic drugs during the first half of this year than in previous years, an analysis by AgencyIQ showed, Politico reported July 27.
In the first half of 2021, the FDA gave full approval to 343 generic drugs and gave 72 tentative approvals. In the first half of 2020, it gave full approval to 361 generic drugs and gave 92 tentative approvals.
The agency has seen a steady decline in new generic drug sumbisisons from drugmakers, Politico reported. In the first half of this year, the FDA received an average of 66 generic drug submissions per month, down from a high of 94 per month in 2017.